StockData
Penumbra Inc logo

Penumbra Inc (PEN) stock

PENNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3073% above fair value
$319.11−1.51 (-0.47%)

Close on Nov 17, 2026Market cap $12.58BP/E 80.4Yield –

Penumbra operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Penumbra's operating income for the twelve months ending Sep 30, 2026 was $189.25M, up 9.5% year over year. For fiscal 2025 it was $189.25M, up 1939.5% from the year before. Over ten years it grew 46.4% a year on average. The highest annual figure on record is $189.25M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$189.25M+1939.5%
FY2024Dec 31, 2024$9.28M-87.4%
FY2023Dec 31, 2023$73.55M+1109.3%
FY2022Dec 31, 2022$6.08M–
FY2021Dec 31, 2021-$7.50M–
FY2020Dec 31, 2020-$38.94M-182.0%
FY2019Dec 31, 2019$47.51M–
FY2018Dec 31, 2018-$852.00K-173.1%
FY2017Dec 31, 2017$1.17M–
FY2016Dec 31, 2016-$1.35M-132.3%
FY2015Dec 31, 2015$4.18M+38.9%
FY2014Dec 31, 2014$3.01M–
FY2013Dec 31, 2013-$1.13M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$50.74M+3.9%
Q2 FY2026Jun 30, 2026$41.04M+0.5%
Q1 FY2026Mar 31, 2026$38.23M-5.2%
Q4 FY2025Dec 31, 2025$59.23M+38.5%
Q3 FY2025Sep 30, 2025$48.84M+38.1%
Q2 FY2025Jun 30, 2025$40.83M–
Q1 FY2025Mar 31, 2025$40.35M+233.4%
Q4 FY2024Dec 31, 2024$42.78M+22.1%
Q3 FY2024Sep 30, 2024$35.36M+180.1%
Q2 FY2024Jun 30, 2024-$80.96M-552.6%
Q1 FY2024Mar 31, 2024$12.10M+51.1%
Q4 FY2023Dec 31, 2023$35.03M+624.8%
Q3 FY2023Sep 30, 2023$12.63M+132.3%
Q2 FY2023Jun 30, 2023$17.89M–
Q1 FY2023Mar 31, 2023$8.01M–
Q4 FY2022Dec 31, 2022$4.83M–
Q3 FY2022Sep 30, 2022$5.43M-38.1%
Q2 FY2022Jun 30, 2022-$139.00K-101.3%
Q1 FY2022Mar 31, 2022-$4.05M-130.1%
Q4 FY2021Dec 31, 2021-$40.06M–
Q3 FY2021Sep 30, 2021$8.78M–
Q2 FY2021Jun 30, 2021$10.31M–
Q1 FY2021Mar 31, 2021$13.46M+2107.0%
Q4 FY2020Dec 31, 2020-$1.75M-116.5%
Q3 FY2020Sep 30, 2020-$20.16M-255.3%
Q2 FY2020Jun 30, 2020-$17.65M-237.9%
Q1 FY2020Mar 31, 2020$610.00K-94.5%
Q4 FY2019Dec 31, 2019$10.58M+58.6%
Q3 FY2019Sep 30, 2019$12.98M–
Q2 FY2019Jun 30, 2019$12.80M+37.9%
Q1 FY2019Mar 31, 2019$11.15M+175.7%
Q4 FY2018Dec 31, 2018$6.67M+73.0%
Q3 FY2018Sep 30, 2018-$20.85M-3152.6%
Q2 FY2018Jun 30, 2018$9.28M–
Q1 FY2018Mar 31, 2018$4.05M–
Q4 FY2017Dec 31, 2017$3.86M–
Q3 FY2017Sep 30, 2017$683.00K–
Q2 FY2017Jun 30, 2017-$1.33M–
Q1 FY2017Mar 31, 2017-$2.05M–
Q4 FY2016Dec 31, 2016-$1.15M–

More Penumbra figures

See a number that looks wrong?